Biomarin Pharmaceutical Inc at Stifel Healthcare Conference (Virtual) Transcript
Awesome. Thanks very much. It's my pleasure to be hosting the BioMarin management team here. We have Hank Fuchs and Brian Mueller. Good to see you guys. Thanks for taking the time away from I'm sure what is probably a busy week for you. Hank, do you want to kick things off and just sort of give a quick update on the company and then I can chime away.
Thanks, Paul. Brian and I appreciate the opportunity to join you today, and we're just a few weeks remaining in '21. We look forward to '22 with great excitement. As the head of R&D, I'm very pleased with the execution of our pipeline pivot from ultra-rare products to products that address more prevalently affected genetic conditions.
Our mission to translate genetic discoveries and the transformative medicines has not changed but the ability to leverage our deep
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |